Oncolytics Biotech Inc. (NASDAQ:ONCY) Receives Average Rating of "Moderate Buy" from Brokerages

robot
Abstract generation in progress

Oncolytics Biotech Inc. (NASDAQ:ONCY) has received an average rating of “Moderate Buy” from five analysts, with a consensus one-year price target of $8.50. Recent insider buying by Andrew Aromando and Patricia Andrews significantly increased their holdings in the company. The stock currently trades at $1.01 with a market capitalization of $107.21 million.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin